Published in Korean J Radiol on June 18, 2012
Surgical treatment of gastric gastrointestinal stromal tumor. J Gastric Cancer (2013) 0.94
A rare submucosal tumour of stomach-glomus tumour: A case report. Int J Surg Case Rep (2015) 0.84
Giant retroperitoneal ancient schwannoma: Is preoperative biopsy always mandatory? Int J Surg Case Rep (2014) 0.78
Clinical implications of doubling time of gastrointestinal submucosal tumors. World J Gastroenterol (2016) 0.75
Differentiation between gastrointestinal schwannomas and gastrointestinal stromal tumors by computed tomography. Oncol Lett (2017) 0.75
CT Features of Colorectal Schwannomas: Differentiation from Gastrointestinal Stromal Tumors. PLoS One (2016) 0.75
Benign gastric schwannoma: how long should we follow up to monitor the recurrence? A case report and comprehensive review of literature of 137 cases. Int Surg (2015) 0.75
Pharmacometric modeling of liver metastases' diameter, volume and density and their relation to clinical outcome in imatinib-treated GIST patients. CPT Pharmacometrics Syst Pharmacol (2017) 0.75
Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol (2002) 20.87
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol (2005) 5.27
Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol (2002) 4.02
Neurogenic tumors in the abdomen: tumor types and imaging characteristics. Radiographics (2003) 3.90
Recent patterns in gastric cancer: a global overview. Int J Cancer (2009) 3.75
Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics (2003) 3.54
A biomathematical approach to clinical tumor growth. Cancer (1962) 3.10
Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. Hum Pathol (1988) 3.03
Gastrointestinal schwannomas: CT features with clinicopathologic correlation. AJR Am J Roentgenol (2005) 2.39
Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol (2000) 2.36
Gastric schwannoma--a clinicopathological analysis of six cases. Histopathology (1995) 2.22
The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc (2002) 2.17
Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration. World J Gastroenterol (2007) 2.12
Benign schwannomas: pathologic basis for CT inhomogeneities. AJR Am J Roentgenol (1986) 2.07
The role of KIT in the management of patients with gastrointestinal stromal tumors. Hum Pathol (2007) 2.02
Benign schwannoma of the digestive tract: a clinicopathologic and immunohistochemical study of five cases, including a case of esophageal tumor. Am J Surg Pathol (1999) 1.93
Schwannomas of the gastrointestinal tract: clinicopathological features of 12 cases including a case of esophageal tumor compared with those of gastrointestinal stromal tumors and leiomyomas of the gastrointestinal tract. Pathol Res Pract (2002) 1.73
Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol (1995) 1.72
Ectopic pancreas: CT findings with emphasis on differentiation from small gastrointestinal stromal tumor and leiomyoma. Radiology (2009) 1.69
Computed tomography in gastrointestinal stromal tumors. Eur Radiol (2003) 1.69
Volume determinations using computed tomography. AJR Am J Roentgenol (1982) 1.55
Gastric schwannomas: radiological features with endoscopic and pathological correlation. Clin Radiol (2008) 1.39
Computed tomography of extracranial nerve sheath tumors with pathological correlation. J Comput Assist Tomogr (1983) 1.29
Gastrointestinal stromal tumor. Correlation of computed tomography findings with tumor grade and mortality. J Comput Assist Tomogr (2003) 1.24
Endosonographic evaluation of c-kit-positive gastrointestinal stromal tumor. Abdom Imaging (2003) 1.23
Gastric stromal tumors: a clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors. Am J Surg Pathol (2002) 1.19
Gastric schwannomas: endosonographic characteristics. Abdom Imaging (2008) 1.16
Glomus tumor of the stomach: CT findings. Abdom Imaging (2001) 1.13
Carcinoid tumors of the stomach: a clinical and radiographic study. AJR Am J Roentgenol (2001) 1.08
Gastrointestinal stromal tumors of the stomach: CT findings and prediction of malignancy. AJR Am J Roentgenol (2004) 1.08
Role of EUS and MDCT in the diagnosis of gastric submucosal tumors according to the revised pathologic concept of gastrointestinal stromal tumors. Eur Radiol (2008) 1.07
Gastric glomus tumor: a hypervascular submucosal tumor on power Doppler endosonography. J Clin Ultrasound (2007) 1.02
Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Ann Surg (2008) 1.01
Cystic changes in intraabdominal extrahepatic metastases from gastrointestinal stromal tumors treated with imatinib. Korean J Radiol (2004) 0.79
Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc (2009) 4.76
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest (2010) 4.22
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol (2011) 4.11
Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet (2012) 4.10
Low-level microsatellite instability in most colorectal carcinomas. Cancer Res (2002) 2.87
Should preoperative chest CT be recommended to all colon cancer patients? Ann Surg (2014) 2.65
Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Radiology (2012) 2.36
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys (2005) 2.19
Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients. Am J Surg Pathol (2007) 2.02
Genetic and phenotypic diversity in breast tumor metastases. Cancer Res (2014) 1.96
Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol (2009) 1.89
Granulocytic sarcoma of bowel: CT findings. Radiology (2007) 1.76
Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study. Cancer Res Treat (2012) 1.76
Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol (2010) 1.75
Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. Ann Surg (2007) 1.74
Treatment of syringoma using an ablative 10,600-nm carbon dioxide fractional laser: a prospective analysis of 35 patients. Dermatol Surg (2011) 1.68
The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. Am J Surg (2008) 1.66
Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncol Rep (2011) 1.66
Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol (2004) 1.65
EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointest Endosc (2007) 1.59
Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol (2005) 1.57
A feasibility study on the expanded indication for endoscopic submucosal dissection of early gastric cancer. Surg Endosc (2010) 1.56
Long-term outcomes after surgery for rheumatic mitral valve disease: valve repair versus mechanical valve replacement. Eur J Cardiothorac Surg (2009) 1.55
Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology (2010) 1.55
Gender-related differences in visceral perception in health and irritable bowel syndrome. J Gastroenterol Hepatol (2006) 1.53
Efficacy and safety of endoscopic treatment for nonampullary sporadic duodenal adenomas. Dig Dis Sci (2013) 1.53
Evaluation of esophageal varices on liver computed tomography: receiver operating characteristic analyses of the performance of radiologists and endoscopists. J Gastroenterol Hepatol (2009) 1.53
PIK3CA mutations in in situ and invasive breast carcinomas. Cancer Res (2010) 1.49
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol (2012) 1.47
The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol (2010) 1.45
Adrenocorticotropin hormone stimulates interleukin-18 expression in human HaCaT keratinocytes. J Invest Dermatol (2007) 1.45
Identification of ROS1 rearrangement in gastric adenocarcinoma. Cancer (2013) 1.43
Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol (2006) 1.43
Changes in the signal- and contrast-to-noise ratios of hepatocellular carcinomas on gadoxetic acid-enhanced dynamic MR imaging. Eur J Radiol (2012) 1.42
Filiform serrated adenoma is an unusual, less aggressive variant of traditional serrated adenoma. Pathology (2012) 1.42
Fasciitis after allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. J Clin Rheumatol (2003) 1.40
[Microsatellite instability in gastric B-cell lymphoma]. Korean J Gastroenterol (2006) 1.39
The stem cell population of the human colon crypt: analysis via methylation patterns. PLoS Comput Biol (2007) 1.38
Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol (2011) 1.38
Diffusion-weighted magnetic resonance imaging for the evaluation of prostate cancer: optimal B value at 3T. Korean J Radiol (2012) 1.33
Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. Mod Pathol (2008) 1.33
High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma. PLoS One (2012) 1.32
Efficacy and tolerability of split-dose magnesium citrate: low-volume (2 liters) polyethylene glycol vs. single- or split-dose polyethylene glycol bowel preparation for morning colonoscopy. Am J Gastroenterol (2010) 1.32
The prognostic significance of tumor-associated stroma in invasive breast carcinoma. Tumour Biol (2012) 1.27
The spectrum of benign esophageal lesions: imaging findings. Korean J Radiol (2002) 1.27
Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37. J Invest Dermatol (2008) 1.26
MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas. Mod Pathol (2013) 1.25
Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod Pathol (2005) 1.24
Polypoid arteriovenous malformation of colon mimicking inflammatory fibroid polyp. J Gastroenterol (2004) 1.23
Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer. Ann Surg Oncol (2009) 1.23
Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointest Endosc (2004) 1.23
Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am J Roentgenol (2008) 1.22
Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea. J Korean Med Sci (2010) 1.21
Needle tract implantation after percutaneous interventional procedures in hepatocellular carcinomas: lessons learned from a 10-year experience. Korean J Radiol (2008) 1.20
Recurrence after curative resection of early gastric cancer. Ann Surg Oncol (2009) 1.19
Hepatic visceral larva migrans of Toxocara canis: CT and sonographic findings. AJR Am J Roentgenol (2006) 1.19
Clinical diagnosis of primary epiploic appendagitis: differentiation from acute diverticulitis. J Clin Gastroenterol (2002) 1.17
Coagulation necrosis induced by radiofrequency ablation in the liver: histopathologic and radiologic review of usual to extremely rare changes. Radiographics (2011) 1.17
Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol (2008) 1.17
Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol (2009) 1.16
Neuroendocrine neoplasms of the gastrointestinal tract: classification, pathologic basis, and imaging features. Radiographics (2007) 1.15
The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT. Eur J Radiol (2010) 1.15
Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology (2012) 1.14
Borrmann type IV: an independent prognostic factor for survival in gastric cancer. J Gastrointest Surg (2008) 1.14
Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea. Cancer Res Treat (2012) 1.14
Prevalence and risk factors of Barrett's esophagus in Korea. J Gastroenterol Hepatol (2007) 1.13
Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res (2002) 1.13
Glomus tumor of the stomach: a clinicopathologic analysis of 10 cases and review of the literature. Gut Liver (2012) 1.12
Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg (2012) 1.11
Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol (2012) 1.11
Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci (2008) 1.11
High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations. PLoS One (2012) 1.09
Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. J Korean Med Sci (2010) 1.08
Bronchogenic cyst of the stomach masquerading as benign stromal tumor. Pathol Int (2005) 1.08
The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy. BMC Cancer (2011) 1.08
Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics (2008) 1.07
Needle tract implantation after sonographically guided percutaneous biopsy of hepatocellular carcinoma: evaluation of doubling time, frequency, and features on CT. AJR Am J Roentgenol (2005) 1.06
Excitotoxic loss of post-synaptic sites is distinct temporally and mechanistically from neuronal death. J Neurochem (2007) 1.05
Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics (2003) 1.05
MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival. Genes Chromosomes Cancer (2010) 1.05
Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy. Korean J Radiol (2009) 1.05
Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol (2005) 1.04
Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection. Virchows Arch (2008) 1.04
Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter). Invest Radiol (2012) 1.03
Nutritional risk index as a predictor of postoperative wound complications after gastrectomy. World J Gastroenterol (2012) 1.03
Preoperative staging of rectal cancer: comparison of 3-T high-field MRI and endorectal sonography. AJR Am J Roentgenol (2006) 1.02